Modelling symptoms to suicide risk in individuals with inflammatory bowel disease - Mihajlovic V, Tripp DA, Jacobson JA.
Given that suicidal behaviour is a pressing concern in inflammatory bowel disease populations, this study sought to model the sequence of variables that lead to its development. Participants (n  = 282) completed online self-report questionnaires ... (Source: SafetyLit)
Source: SafetyLit - February 11, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Biomedical sciences researcher gets $1.67 million federal grant to study gut immunity
(Georgia State University) Dr. Tim Denning, professor and associate director of the Institute for Biomedical Sciences at Georgia State University, has received a four-year, $1.67 million federal grant to study how an immunological pathway influences inflammatory signaling in the intestine that can lead to chronic human diseases such as inflammatory bowel disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 7, 2020 Category: International Medicine & Public Health Source Type: news

Dynamo: How Crohn's made me '150% better at magic'
The magician recalls how his poor health nearly robbed him of the use of his hands to perform. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - February 5, 2020 Category: Consumer Health News Source Type: news

Incidence of adverse psychiatric events during treatment of inflammatory bowel disease with biologic therapies: a systematic review - Jain A, Marrie RA, Shafer LA, Graff LA, Patten SB, El-Gabalawy R, Sareen J, Bolton JM, Fisk JD, Bernstein CN.
We conducted a systematic review and a fixed-effects meta-analysis to determine whether incident adverse psychiatric events (APE) including depression, anxiety, psychosis, or suicide were associated with biologic therapy in IBD. Six randomized controlled t... (Source: SafetyLit)
Source: SafetyLit - February 3, 2020 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Tofacitinib Maintenance Dose for Patients With UC Tofacitinib Maintenance Dose for Patients With UC
This study analyzed the efficacy and safety of two adjustments of tofacitinib maintenance dosing for patients with ulcerative colitis.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 3, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Biologics May Have Changed the Natural History of Ulcerative Colitis Biologics May Have Changed the Natural History of Ulcerative Colitis
The rate of colectomy within the first year after hospital admission for ulcerative colitis has declined in the modern era of biologics, suggesting the advent of biologic therapy has changed the natural history of the disease, researchers report.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 30, 2020 Category: Surgery Tags: Gastroenterology News Source Type: news

Simple Changes Improve Patient Care Across 26 Sites Simple Changes Improve Patient Care Across 26 Sites
Small adjustments in the urgent care of patients with inflammatory bowel disease can lead to substantial improvements, a collaborative initiative confirms.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 29, 2020 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Disability, Quality of Life, Mood May Affect Sleep in IBD Patients
WEDNESDAY, Jan. 29, 2020 -- Sleep quality is associated with mood state, disability, and quality of life among patients with inflammatory bowel disease (IBD), according to a study published online Jan. 16 in Scientific Reports. Carla Marinelli, from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 29, 2020 Category: Pharmaceuticals Source Type: news

Don't cut salt completely: Study discovers that high-salt diets inhibit tumor growth
(Natural News) Having too much salt in your diet is incredibly unhealthy. High-salt intake can exacerbate conditions like multiple sclerosis and inflammatory bowel diseases. However, when it comes to cancer, a team of researchers is now suggesting that increasing the amount of salt in your diet may have some beneficial effects, particularly when it comes to fighting... (Source: NaturalNews.com)
Source: NaturalNews.com - January 25, 2020 Category: Consumer Health News Source Type: news

Lymphoma Risk Low After TNF Inhibitor Treatments Lymphoma Risk Low After TNF Inhibitor Treatments
Tumor necrosis factor (TNF) inhibitors are among the most effective treatments for inflammatory bowel disease, but questions about cancer risk have kept some clinicians from prescribing them.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 25, 2020 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Vedolizumab and Malignancy Incidence Vedolizumab and Malignancy Incidence
This study analyzed the long-term incidence of malignancy with vedolizumab, a gut-selective antibody approved to treat moderate-to-severe Crohn's disease and ulcerative colitis in adults.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 22, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Serum S100A8/A9 as a Potentially Sensitive Biomarker for IBD Serum S100A8/A9 as a Potentially Sensitive Biomarker for IBD
Are serum S100A8/A9 measurements a sensitive marker for inflammatory bowel disease? How does it compare with other inflammatory biomarkers?Laboratory Medicine (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - January 22, 2020 Category: Pathology Tags: Pathology & Lab Medicine Journal Article Source Type: news

IBD Diagnoses Rising in Children IBD Diagnoses Rising in Children
Advances in anti-TNF drugs will be in the spotlight at the upcoming Crohn's and Colitis Congress. One expert believes a cure will come in the lifetime of some of the children he currently treats.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 21, 2020 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Researchers identify a possible cause and treatment for inflammatory bowel disease
(Chinese Academy of Sciences Headquarters) In a study published online in PNAS on Jan. 20, 2020, Prof. SUN Bing's team from the Center for Excellence in Molecular and Cellular Science, Institute of Biochemistry and Cell Biology of the Chinese Academy of Sciences, in collaboration with Prof. LIU Jie from Huashan Hospital, Fudan University, revealed a new mechanism involved in the pathogenesis of IBD and suggested therapeutic targets for clinical trial. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 21, 2020 Category: International Medicine & Public Health Source Type: news

New AGA guideline outlines treatment best practices for ulcerative colitis patients
(American Gastroenterological Association) An increasing number of drugs are available for long-term management of moderate to severe UC, leading to questions about treatment strategies for optimal patient care. A new clinical guideline from the American Gastroenterological Association, published in Gastroenterology, the official journal of the AGA Institute, provides recommendations for the management of adult outpatients with moderate to severe UC as well as adult hospitalized patients with acute severe ulcerative colitis (ASUC). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 21, 2020 Category: International Medicine & Public Health Source Type: news

Don't cut salt completely: Animal study discovers that high-salt diets can inhibit tumor growth
(Natural News) Having too much salt in your diet is incredibly unhealthy. High-salt intake can exacerbate conditions like multiple sclerosis and inflammatory bowel diseases. However, when it comes to cancer, a team of researchers is now suggesting that increasing the amount of salt in your diet may have some beneficial effects, particularly when it comes to fighting... (Source: NaturalNews.com)
Source: NaturalNews.com - January 20, 2020 Category: Consumer Health News Source Type: news

Colorectal Cancer Risk Still Up in Patients With Ulcerative Colitis
Even after adjustment for tumor stage, patients with ulcerative colitis have higher risk for CRC mortality (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 17, 2020 Category: Cancer & Oncology Tags: Family Medicine, Gastroenterology, Internal Medicine, Oncology, Journal, Source Type: news

Colorectal Cancer Risk Still Up in Patients With Ulcerative Colitis
FRIDAY, Jan. 17, 2020 -- Patients with ulcerative colitis have an increased risk for colorectal cancer and colorectal cancer mortality, according to a study published in the Jan. 11 issue of The Lancet. Ola Ol én, M.D., from the Karolinska... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 17, 2020 Category: Pharmaceuticals Source Type: news

Fungal Alterations in Inflammatory Bowel Diseases Fungal Alterations in Inflammatory Bowel Diseases
This review explores the role of gut fungi in patients with Crohn's disease and ulcerative colitis. Might modulation of the fungal microbiota present a therapeutic opportunity for IBD?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 15, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Crohn's Disease
Title: Crohn's DiseaseCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 1/14/2020 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - January 14, 2020 Category: Nutrition Source Type: news

Disease Activity, Treatment De-Escalation Tied to Postpartum IBD Flare Risk Disease Activity, Treatment De-Escalation Tied to Postpartum IBD Flare Risk
Women with inflammatory bowel disease (IBD) have a one-in-three chance of experiencing a disease flare during the postpartum year, new findings show.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 14, 2020 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Vitamin D Status and Clinical Outcomes in Adults With IBD Vitamin D Status and Clinical Outcomes in Adults With IBD
Vitamin D deficiency is highly prevalent among patients with inflammatory bowel disease. How does low vitamin D status impact disease activity, inflammation, relapse and quality of life?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 13, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

IBD May Increase Risk for Adverse Pregnancy Outcomes
THURSDAY, Jan. 9, 2020 -- Women with inflammatory bowel disease (IBD) more often have gestational diabetes and preterm premature rupture of membranes, according to a review published online Jan. 7 in Alimentary Pharmacology and Therapeutics. Parul... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 9, 2020 Category: Pharmaceuticals Source Type: news

Colorectal cancer risk remains despite modern treatment for ulcerative colitis
(Karolinska Institutet) Patients with the inflammatory bowel disease ulcerative colitis have a higher risk of dying from colorectal cancer, despite modern therapy, even though the risk has declined in recent years. This is according to a new study published in the scientific journal The Lancet by a team of Swedish and Danish researchers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 9, 2020 Category: Cancer & Oncology Source Type: news

Stopping Anti-TNF Therapy in Perianal Crohn's Disease Stopping Anti-TNF Therapy in Perianal Crohn's Disease
Does stopping anti-TNF therapy in patients with perianal Crohn's disease result in relapse?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 8, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Does inflammatory bowel disease carry certain risks during pregnancy?
(Wiley) Pregnant women with inflammatory bowel disease (IBD) are more likely to undergo delivery by Caesarean section and face certain risks during pregnancy, according to an analysis published in Alimentary Pharmacology& Therapeutics. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 8, 2020 Category: International Medicine & Public Health Source Type: news

Medical News Today: What to know about Crohn's and the eyes
Although most Crohn's disease symptoms involve the gut, the condition can also affect the eyes. Learn more about eye-related Crohn's symptoms here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 7, 2020 Category: Consumer Health News Tags: Crohn's / IBD Source Type: news

Ultrasound Effective in Monitoring Ulcerative Colitis Ultrasound Effective in Monitoring Ulcerative Colitis
Intestinal ultrasound (IUS) is an effective non-invasive tool for monitoring disease - and possibly treatment response - in patients with ulcerative colitis (UC), according to German researchers.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 6, 2020 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Zr-89 immuno-PET could help predict cancer therapy outcomes
Researchers are one step closer to proving the worth of zirconium-89 (Zr-89)...Read more on AuntMinnie.comRelated Reading: ImaginAb touts research on T-cell PET imaging agent Immuno-PET could aid patients with inflammatory diseases PET tracer may aid diagnosis of inflammatory bowel disease Immuno-PET tracer offers hope for early cancer treatment (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 18, 2019 Category: Radiology Source Type: news

IBD Biomarker Unknowns Complicate Treatment IBD Biomarker Unknowns Complicate Treatment
With no way to predict which patient with inflammatory bowel disease will respond to which drug, clinicians often have to use trial and error as a strategy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 17, 2019 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Doctors warn Crohn's, arthritis patients will pay a price as Alberta pulls drug funding
Doctors say 2,000 patients in Alberta will pay a price with the government's plan to stop funding Remicade, a drug used to treat people with Crohn's and colitis. (Source: CBC | Health)
Source: CBC | Health - December 17, 2019 Category: Consumer Health News Tags: News/Canada/Calgary Source Type: news

Research adds new twist to fight against autoimmune diseases
(Cincinnati Children's Hospital Medical Center) Scientists describe in Nature Immunology an entirely new molecular process in mice that triggers T cell-driven inflammation and causes different auto-immune diseases. In a study published online Dec. 17, say their data have implications for Multiple Sclerosis, Type 1 diabetes and Inflammatory Bowel Disease. It also will help efforts to find better treatments for autoimmune disease, still an urgent need in medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 17, 2019 Category: Cancer & Oncology Source Type: news

Patients With IBD Prone to Irritable Bowel Syndrome Patients With IBD Prone to Irritable Bowel Syndrome
Patients in remission from inflammatory bowel disease are susceptible to irritable bowel syndrome, but diet, cognitive therapy, and medication can help treat the symptoms.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 16, 2019 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Inflammatory Bowel Disease Ups Risk for Serious Viral Infections
MONDAY, Dec. 16, 2019 -- Patients with inflammatory bowel disease (IBD) have a threefold higher risk for systemic serious viral infections (SVIs) compared with the general population, according to a study published online Nov. 14 in the United... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 16, 2019 Category: Pharmaceuticals Source Type: news

Reporters invited to attend Crohn's & Colitis Congress ®
(American Gastroenterological Association) Register for the Crohn's& Colitis Congress, taking place Jan. 23-25, 2020, in Austin, Texas, and learn about the latest trends and research in inflammatory bowel disease (IBD) patient care. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 16, 2019 Category: International Medicine & Public Health Source Type: news

Biosimilar for Crohn's Noninferior to Adalimumab Biosimilar for Crohn's Noninferior to Adalimumab
A patent dispute means that the marketing of a biosimilar for patients with inflammatory bowel disease will be delayed, despite approval by the US Food and Drug Administration, investigators report.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 15, 2019 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

1999 to 2017 Saw Drop in IBD Hospitalization Rate for Whites
THURSDAY, Dec. 12, 2019 -- From 1999 to 2017, the hospitalization rate for Crohn disease and ulcerative colitis decreased among non-Hispanic white Medicare beneficiaries aged ≥65 years, but not among non-Hispanic blacks, according to research... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 12, 2019 Category: Pharmaceuticals Source Type: news

FDA Approves Xeljanz XR (tofacitinib) Extended-Release Tablets for the Treatment of Ulcerative Colitis
December 12, 2019 - Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved Xeljanz XR (tofacitinib) extended-release 11 mg and 22 mg tablets for the once-daily treatment of adult patients with moderately... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 12, 2019 Category: Drugs & Pharmacology Source Type: news

Hospitalizations for Inflammatory Bowel Disease Among Medicare Fee-For-Service Beneficiaries --- United States, 1999--2017
From 1999 to 2017, hospitalization rates for inflammatory bowel disease decreased among non-Hispanic white Medicare beneficiaries but not among non-Hispanic black Medicare beneficiaries. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - December 12, 2019 Category: American Health Tags: Inflammatory Bowel Disease (IBD) Medicare Beneficiaries MMWR Morbidity & Mortality Weekly Report Source Type: news

A vaccine against chronic inflammatory diseases
Chronic inflammatory bowel diseases, such as Crohn's Disease and ulcerative colitis, are linked to abnormalities of the gut microbiota in humans and in animals. Patients generally present reduced bacterial diversity in their intestinal flora along with excessive levels of bacteria that express a protein called flagellin, which favors their mobility. (Source: World Pharma News)
Source: World Pharma News - December 11, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

A vaccine against chronic inflammatory diseases
(INSERM (Institut national de la sant é et de la recherche m é dicale)) In animals, a vaccine modifying the composition and function of the gut microbiota provides protection against the onset of chronic inflammatory bowel diseases and certain metabolic disorders, such as diabetes and obesity. This research was conducted by the team of Beno î t Chassaing, Inserm researcher at Institut Cochin (Inserm/CNRS/Universit é de Paris), whose initial findings have been published in Nature Communications. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 11, 2019 Category: International Medicine & Public Health Source Type: news

Teams of microbes are at work in our bodies. Here's how to figure out what they're doing
(Drexel University) An algorithm akin to the annoyingly helpful one that attempts to auto-complete text messages and emails is now being harnessed for a better cause. A group of Drexel University researchers are using its pattern-recognition ability to identify microbial communities in the body by sifting through volumes of genetic code. Their method could speed the development of medical treatments for microbiota-linked ailments like Crohn's disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 11, 2019 Category: International Medicine & Public Health Source Type: news

Specialized immune cells could help repair inflammatory bowel disease damage in children
(University of British Columbia) A new study suggests that specialized immune cells that dampen inflammation and help repair the gut could be used as a potential therapy for children dealing with the painful symptoms of inflammatory bowel disease (IBD). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 10, 2019 Category: International Medicine & Public Health Source Type: news

Gut feeling: A network approach towards understanding IBD
(Earlham Institute) Scientists at the Earlham Institute (EI), Quadram Institute Bioscience (QIB) and the University of East Anglia (UEA), UK, have pioneered how to get very detailed transcriptomics data from gut organoids, and regulatory networks to analyse them -- establishing a pipeline that can be used to explore the causes of Inflammatory Bowel Disease (IBD). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 10, 2019 Category: International Medicine & Public Health Source Type: news

Long-duration Vancomycin Linked to Lower Rates of C. Diff Recurrence in IBD Long-duration Vancomycin Linked to Lower Rates of C. Diff Recurrence in IBD
In patients with inflammatory bowel disease (IBD), a long course of oral vancomycin is associated with lower odds of Clostridioides difficile infection recurrence than a short course, a retrospective chart review reveals.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - December 7, 2019 Category: Pathology Tags: Gastroenterology News Source Type: news

Young people with IBD five times more likely to develop serious infections
(SAGE) Young patients with inflammatory bowel disease (IBD) are five times more likely than the general population to develop viral infections that can lead to hospitalisation or permanent organ damage, a new study published in the UEG Journal has found. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 5, 2019 Category: International Medicine & Public Health Source Type: news

Emerging Treatment Options for Crohn's Emerging Treatment Options for Crohn's
Drug therapies and the postoperative management of patients will be in the spotlight at the upcoming Advances in Inflammatory Bowel Diseases conference.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 4, 2019 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Endoscopic Techniques for Dysplasia Surveillance in IBD Endoscopic Techniques for Dysplasia Surveillance in IBD
Which endoscopic procedure best identifies neoplasia in patients with ulcerative colitis or Crohn disease?Alimentary Pharmacology & Therapeutics (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - December 4, 2019 Category: Allergy & Immunology Tags: Gastroenterology Journal Article Source Type: news

Drug decreases gut leakiness associated with ulcerative colitis
(University of California - Riverside) A research team led by biomedical scientists at the University of California, Riverside, has found that a drug approved by the FDA to treat rheumatoid arthritis and ulcerative colitis can repair permeability defects in the gut's epithelium. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 4, 2019 Category: International Medicine & Public Health Source Type: news

Drinking kudingcha can help lower your risk of colitis
(Natural News) Researchers from the Chongqing University of Education in China looked at the potential of functional foods – in particular, kudingcha or kuding tea – to treat ulcerative colitis. They found that kuding tea could help treat and prevent ulcerative colitis without side effects. Kuding tea is a bitter-tasting tea which is popular in China. It is used to quench thirst,... (Source: NaturalNews.com)
Source: NaturalNews.com - December 2, 2019 Category: Consumer Health News Source Type: news